276 related articles for article (PubMed ID: 8009701)
1. [Hyperuricemia].
Slot O
Ugeskr Laeger; 1994 Apr; 156(16):2396-401. PubMed ID: 8009701
[TBL] [Abstract][Full Text] [Related]
2. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of renal urate excretion].
Häntzschel U; Költzsch V
Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
Becker MA
Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis, clinical findings and management of acute and chronic gout.
Corrado A; D'Onofrio F; Santoro N; Melillo N; Cantatore FP
Minerva Med; 2006 Dec; 97(6):495-509. PubMed ID: 17213786
[TBL] [Abstract][Full Text] [Related]
6. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.
Calabrese G; Simmonds HA; Cameron JS; Davies PM
Q J Med; 1990 May; 75(277):441-50. PubMed ID: 2388995
[TBL] [Abstract][Full Text] [Related]
7. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
Darmawan J; Rasker JJ; Nuralim H
J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and therapy of disorders of purine metabolism].
Schröder HE; Thiele P; Heidelmann G
Z Gesamte Inn Med; 1982 Jul; 37(13):431-6. PubMed ID: 7136086
[TBL] [Abstract][Full Text] [Related]
9. Hyperuricaemia: more than just a cause of gout?
Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis, diagnostics and therapy of gout].
Zurek M
Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
[TBL] [Abstract][Full Text] [Related]
11. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
Kanellis J; Feig DI; Johnson RJ
Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
[TBL] [Abstract][Full Text] [Related]
12. [Gouty nephropathy (a review of the literature)].
Siniachenko OV; Diadyk AI; Vasilenko IV
Vrach Delo; 1984 Jul; (7):96-100. PubMed ID: 6475032
[No Abstract] [Full Text] [Related]
13. [Evaluation of hyperuricemia caused by fructose in a status of altered uric acid metabolism].
Menghini S; Della Corte E
Quad Sclavo Diagn; 1987 Dec; 23(4):441-6. PubMed ID: 3509875
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of hyperuricemia and gout].
Pöllmann G; Kullich W; Klein G
Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
[TBL] [Abstract][Full Text] [Related]
15. [How to treat hyperuricemia?].
Favre H
Schweiz Med Wochenschr; 1984 Sep; 114(37):1269-71. PubMed ID: 6484556
[TBL] [Abstract][Full Text] [Related]
16. [Hyperuricemia: explain, ignore or treat?].
Kummer H
Schweiz Med Wochenschr; 1986 Jun; 116(24):797-801. PubMed ID: 3726511
[TBL] [Abstract][Full Text] [Related]
17. New insights into the epidemiology of gout.
Doherty M
Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
[TBL] [Abstract][Full Text] [Related]
18. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
[TBL] [Abstract][Full Text] [Related]
19. Overview of hyperuricaemia and gout.
Masseoud D; Rott K; Liu-Bryan R; Agudelo C
Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
[TBL] [Abstract][Full Text] [Related]
20. Gout, uric acid and renal disease.
Emmerson BT
Med J Aust; 1976 Mar; 1(12):403-5. PubMed ID: 1272125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]